Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus--present and future perspectives. Nat Rev Endocrinol. 2011;8(4):228–36.
Article
Google Scholar
Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest. 2000;106(4):473–81.
CAS
Article
Google Scholar
Tasyurek HM, Altunbas HA, Balci MK, et al. Incretins: their physiology and application in the treatment of diabetes mellitus. Diabetes Metab Res Rev. 2014;30(5):354–71.
CAS
Article
Google Scholar
Nauck M. Incretin therapies: highlighting common features and differences in the modes of action of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors. Diabetes Obes Metab. 2016r;18(3):203–16.
CAS
Article
Google Scholar
Maleckas A, Venclauskas L, Wallenius V, et al. Surgery in the treatment of type 2 diabetes mellitus. Scand J Surg. 2015;104(1):40–7.
CAS
Article
Google Scholar
De Luca M, Angrisani L, Himpens J, et al. Indications for surgery for obesity and weight-related diseases: position statements from the International Federation for the Surgery of obesity and metabolic disorders (IFSO). Obes Surg. 2016;26(8):1659–96.
Article
Google Scholar
Thaler JP, Cummings DE. Minireview: hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology. 2009;150(6):2518–25.
CAS
Article
Google Scholar
Wickremesekera K, Miller G, Naotunne TD, et al. Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study. Obes Surg. 2005;15(4):474–81.
Article
Google Scholar
Vetter ML, Cardillo S, Rickels MR, et al. Narrative review: effect of bariatric surgery on type 2 diabetes mellitus. Ann Intern Med. 2009;150(2):94–103.
Article
Google Scholar
Korner J, Bessler M, Cirilo LJ, et al. Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin. J Clin Endocrinol Metab. 2005;90(1):359–65.
CAS
Article
Google Scholar
Sagar PM. Surgical treatment of morbid obesity. Br J Surg. 1995;82(6):732–9.
CAS
Article
Google Scholar
Crookes PF. Surgical treatment of morbid obesity. Annu Rev Med. 2006;57:243–64.
CAS
Article
Google Scholar
Sun Y, Chen J. Intestinal electric stimulation decreases fat absorption in rats: therapeutic potential for obesity. Obes Res. 2004;12(8):1235–42.
CAS
Article
Google Scholar
Aberle J, Busch P, Veigel J, Duprée A, Roesch T, Zu Eulenburg C, et al. Duodenal electric stimulation: results of a first-in-man study. Obes Surg 2016;26(2):369–375.
Yin J, Zhang J, Chen JDZ. Inhibitory effects of intestinal electrical stimulation on food intake, weight loss and gastric emptying in rats. Am J Phys Regul Integr Comp Phys. 2007;293(1):R78–82.
CAS
Google Scholar
Li S, Chen JDZ. Pulse width-dependent effects of intestinal electrical stimulation for obesity: role of gastrointestinal motility and hormones. Obes Surg. 2017;27(1):70–7.
Article
Google Scholar
Gautam D, Gavrilova O, Jeon J, et al. Beneficial metabolic effects of M3 muscarinic acetylcholine receptor deficiency. Cell Metab. 2006;4(5):363–75.
CAS
Article
Google Scholar
Chen JDZ, Yin J, Wei W. Electrical therapies for gastrointestinal motility disorders. Expert Rev Gastroenterol Hepatol. 2017;11(5):407–18.
CAS
Article
Google Scholar
Li S, Chen JDZ. Cellular effects of gastric electrical stimulation on antral smooth muscle cells in rats. Am J Phys Regul Integr Comp Phys. 2010;298(6):R1580–7.
CAS
Google Scholar
Li S, Zhu W, Zhang S, et al. Chronic intestinal electrical stimulation improves glucose intolerance and insulin resistance in diet-induced obesity rats. Obes Silver Spring Md. 2017;25(6):1061–8.
CAS
Article
Google Scholar
Liu J, Xiang Y, Qiao X, et al. Hypoglycemic effects of intraluminal intestinal electrical stimulation in healthy volunteers. Obes Surg. 2011;21(2):224–30.
Article
Google Scholar
Ouyang X, Li S, Tan Y, et al. Intestinal electrical stimulation attenuates hyperglycemia and prevents loss of pancreatic β cells in type 2 diabetic Goto-Kakizaki rats. Nutr Diabetes. 2019;9(1):4.
Article
Google Scholar
Tolhurst G, Reimann F, Gribble FM. Nutritional regulation of glucagon-like peptide-1 secretion. J Physiol. 2009;587(Pt 1):27–32.
CAS
Article
Google Scholar
Anini Y, Fu-Cheng X, Cuber JC, et al. Comparison of the postprandial release of peptide YY and proglucagon-derived peptides in the rat. Pflugers Arch. 1999;438(3):299–306.
CAS
Article
Google Scholar
Gutzwiller JP, Göke B, Drewe J, et al. Glucagon-like peptide-1: a potent regulator of food intake in humans. Gut. 1999;44(1):81–6.
CAS
Article
Google Scholar
Baggio LL, Drucker DJ. Biology of incretins: GLP-1 and GIP. Gastroenterology. 2007;132(6):2131–57.
CAS
Article
Google Scholar
Rask E, Olsson T, Söderberg S, et al. Impaired incretin response after a mixed meal is associated with insulin resistance in nondiabetic men. Diabetes Care. 2001;24(9):1640–5.
CAS
Article
Google Scholar
Sandoval D, Dunki-Jacobs A, Sorrell J, et al. Impact of intestinal electrical stimulation on nutrient-induced GLP-1 secretion in vivo. Neurogastroenterol Motil. 2013;25(8):700–5.
CAS
Article
Google Scholar
Theodorakis MJ, Carlson O, Michopoulos S, et al. Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP. Am J Physiol Endocrinol Metab. 2006;290(3):E550–9.
CAS
Article
Google Scholar
Rocca AS, Brubaker PL. Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion. Endocrinology. 1999;140(4):1687–94.
CAS
Article
Google Scholar
Christensen MB. Glucose-dependent insulinotropic polypeptide: effects on insulin and glucagon secretion in humans. Dan Med J. 2016;63(4)
Parker HE, Habib AM, Rogers GJ, et al. Nutrient-dependent secretion of glucose-dependent insulinotropic polypeptide from primary murine K cells. Diabetologia. 2009;52(2):289–98.
CAS
Article
Google Scholar
Anini Y, Brubaker PL. Muscarinic receptors control glucagon-like peptide 1 secretion by human endocrine L cells. Endocrinology. 2003;144(7):3244–50.
CAS
Article
Google Scholar
Cellini J, Jukic AMZ, LePard KJ. Neostigmine-induced contraction and nitric oxide-induced relaxation of isolated ileum from STZ diabetic guinea pigs. Auton Neurosci Basic Clin. 2011;165(2):178–90.
CAS
Article
Google Scholar
Anini Y, Hansotia T, Brubaker PL. Muscarinic receptors control postprandial release of glucagon-like peptide-1: in vivo and in vitro studies in rats. Endocrinology. 2002;143(6):2420–6.
CAS
Article
Google Scholar
Xu X, Lei Y, Chen JDZ. Duodenum electrical stimulation delays gastric emptying, reduces food intake and accelerates small bowel transit in pigs. Obes Silver Spring Md. 2011;19(2):442–8.
Article
Google Scholar
Wang WF, Yin JY, De Dz Chen J. Acceleration of small bowel transit in a canine hypermotility model with intestinal electrical stimulation. J Dig Dis. 2015;16(3):135–42.
CAS
Article
Google Scholar
Gautam D, Han S-J, Hamdan FF, et al. A critical role for beta cell M3 muscarinic acetylcholine receptors in regulating insulin release and blood glucose homeostasis in vivo. Cell Metab. 2006;3(6):449–61.
CAS
Article
Google Scholar
Ito Y, Kaji M, Sakamoto E, et al. The beneficial effects of a muscarinic agonist on pancreatic β-cells. Sci Rep. 2019;9(1):16180.
Article
Google Scholar
Abello J, Ye F, Bosshard A, et al. Stimulation of glucagon-like peptide-1 secretion by muscarinic agonist in a murine intestinal endocrine cell line. Endocrinology. 1994;134(5):2011–7.
CAS
Article
Google Scholar
Zhang J, Zhu H, Chen JDZ. Central neuronal mechanisms of intestinal electrical stimulation: effects on duodenum distention-responsive (DD-R) neurons in the VMH of rats. Neurosci Lett. 2009;457(1):27–31.
CAS
Article
Google Scholar
Sun Y, Qin C, Foreman RD, et al. Intestinal electric stimulation modulates neuronal activity in the nucleus of the solitary tract in rats. Neurosci Lett. 2005;385(1):64–9.
CAS
Article
Google Scholar